

(Sharecast News) - AIM-listed specialist drug discovery and development company ImmuPharma insisted on Wednesday that it is not looking to raise funds...


ImmuPharma Confirms It Will Not Raise Funds Despite Share Price Rise


(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced a licence and development agreement with Avion Pharmaceutica...


Immupharma Shares Take Off On Lupuzor US Licencing Deal With Avion


LONDON, Nov 28 (Reuters) - British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, ...


ImmuPharma Loss Narrows Slightly, Focus On Lupuzor Regulatory Approval


(Alliance News) - Immupharma PLC on Friday reported analysis of the results from the study of Lupuzor, its lead programme for the potential breakthrou...


(Sharecast News) - Specialist drug discovery and development company ImmuPharma released the analysis of results from the open-label six month extensi...